MorphoSys Digitalizes Large-molecule R&D with Genedata Biologics
Markus Enzelberger, CSO of Morphosys, on biopharma R&D requirements and their deployment of Genedata Biologics: Ten years ago, when MorphoSys looked for a partner to help them digitalize their biopharma R&D, they quickly discovered that the systems designed for small molecules could not handle their specific needs for large-molecule because the tasks and workflows are completely different. Then they found Genedata – a company who really understands how to work with biotherapeutics. They were an early adopter of Genedata Biologics, a built for biologics solution, which increases efficiency and dramatically improves process quality. Since then, MorphoSys and Genedata have developed a close and collaborative relationship.